Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 19

Работа: Design, synthesis, biological evaluation of a new tricyclicthiazolopy‐rimidinone derivatives as acetylcholinesterase inhibitors

  1. Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐<i>a</i>]thiazolo[5,4‐<i>d</i>]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

    Yan Zeng, Lifei Nie, Liu Liu +6

    СтатьяCholinesterase and Neurodegenerative DiseasesJournal of Heterocyclic Chemistry2022Цитирований: 17
    ABI

  2. Diversity-oriented synthesis of amide derivatives of tricyclic thieno[2,3- <i>d</i> ]pyrimidin-4(3 <i>H</i> )-ones and evaluation of their influence on melanin synthesis in murine B16 cells

    Li Fei Nie, Guozheng Huang, Khurshed Bozorov +4

    СтатьяSynthesis of Organic CompoundsHeterocyclic Communications2018Цитирований: 15
    ABI

  3. <scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

    Yan Zeng, Lifei Nie, Khurshed Bozorov +4

    СтатьяQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry2021Цитирований: 11
    ABI

  4. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

    Fang Ma, Hongtao Du

    Статья2017Цитирований: 6
    ABI

  5. Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme

    Hai‐Jing Zhong, Ka‐Ho Leung, Sheng Lin +5

    Статья2014Цитирований: 5
    ABI

  6. Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease

    Hongtao Du, Xinlian Liu, Jusen Xie +1

    Статья2019Цитирований: 5
    ABI

  7. Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode

    Fouad H. Darras, Sarah Wehle, Guozheng Huang +2

    Статья2014Цитирований: 3
    ABI

  8. Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

    Muriel Noetzli, Chin B. Eap

    Обзорная статья2013Цитирований: 3
    ABI

  9. Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease

    Ramón Cacabelos, Clara Torrellas, Óscar Teijido +1

    Обзорная статья2016Цитирований: 3
    ABI

  10. Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

    Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir +4

    Обзорная статья2018Цитирований: 3
    ABI

  11. A review on cholinesterase inhibitors for Alzheimer’s disease

    Preet Anand, Baldev Singh

    Обзорная статья2013Цитирований: 2
    ABI

  12. Peroxide-Mediated Oxidative Radical Cyclization to the Quinazolinone System: Efficient Syntheses of Deoxyvasicinone, Mackinazolinone and (±)-Leucomidine C

    Luis D. Miranda, Jazmín García-Ramírez

    Статья2020Цитирований: 2
    ABI

  13. Crystal structure, Hirshfeld surface analysis and energy framework study of 6-formyl-7,8,9,11-tetrahydro-5<i>H</i>-pyrido[2,1-<i>b</i>]quinazolin-11-one

    Akmaljon Tojiboev, Sherzod Zhurakulov, Валентина И. Виноградова +2

    СтатьяQuinazolinone synthesis and applicationsActa Crystallographica Section E Crystallographic Communications2020Цитирований: 2
    ABI

  14. Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice

    Elisabet Viayna, Nicolas Coquelle, Monika Cieslikiewicz‐Bouet +23

    Статья2020Цитирований: 2
    ABI

  15. Discovery of Novel Tacrine–Pyrimidone Hybrids as Potent Dual AChE/GSK-3 Inhibitors for the Treatment of Alzheimer’s Disease

    Hong Yao, Giuseppe Uras, Pengfei Zhang +11

    Статья2021Цитирований: 2
    ABI

  16. Без названия

    ДругоеЦитирований: 1
    ABI

  17. Без названия

    ДругоеЦитирований: 1
    ABI

  18. Без названия

    ДругоеЦитирований: 1
    ABI

  19. Без названия

    ДругоеЦитирований: 1
    ABI